231 related articles for article (PubMed ID: 35583867)
1. Utility of Biomarkers for Sepsis-Associated Acute Kidney Injury Staging.
Molinari L; Del Rio-Pertuz G; Smith A; Landsittel DP; Singbartl K; Palevsky PM; Chawla LS; Huang DT; Yealy DM; Angus DC; Kellum JA;
JAMA Netw Open; 2022 May; 5(5):e2212709. PubMed ID: 35583867
[TBL] [Abstract][Full Text] [Related]
2. Association of Renal Stress/Damage and Filtration Biomarkers with Subsequent AKI during Hospitalization among Patients Presenting to the Emergency Department.
Kimmel M; Shi J; Latus J; Wasser C; Kitterer D; Braun N; Alscher MD
Clin J Am Soc Nephrol; 2016 Jun; 11(6):938-946. PubMed ID: 27026519
[TBL] [Abstract][Full Text] [Related]
3. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
[TBL] [Abstract][Full Text] [Related]
4. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure.
Schanz M; Shi J; Wasser C; Alscher MD; Kimmel M
Clin Cardiol; 2017 Jul; 40(7):485-491. PubMed ID: 28295429
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
[TBL] [Abstract][Full Text] [Related]
6. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
[TBL] [Abstract][Full Text] [Related]
7. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
[TBL] [Abstract][Full Text] [Related]
8. (TIMP2) x (IGFBP7) as early renal biomarker for the prediction of acute kidney injury in aortic surgery (TIGER). A single center observational study.
Waskowski J; Pfortmueller CA; Schenk N; Buehlmann R; Schmidli J; Erdoes G; Schefold JC
PLoS One; 2021; 16(1):e0244658. PubMed ID: 33411755
[TBL] [Abstract][Full Text] [Related]
9. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.
Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A
PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717
[TBL] [Abstract][Full Text] [Related]
10. Predictive performance of two types of urinary biomarkers for renal non-recovery in sepsis-associated acute kidney injury: a prospective observational study.
Licheng ; Jia H; Jiang Y; Li W
BMC Nephrol; 2024 May; 25(1):153. PubMed ID: 38702662
[TBL] [Abstract][Full Text] [Related]
11. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
[TBL] [Abstract][Full Text] [Related]
12. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.
Titeca-Beauport D; Daubin D; Van Vong L; Belliard G; Bruel C; Alaya S; Chaoui K; Andrieu M; Rouquette-Vincenti I; Godde F; Pascal M; Diouf M; Vinsonneau C; Klouche K; Maizel J
Crit Care; 2020 Jun; 24(1):280. PubMed ID: 32487237
[TBL] [Abstract][Full Text] [Related]
13. Tissue Inhibitor Metalloproteinase-2·IGF-Binding Protein 7 for the Prediction of Acute Kidney Injury following Cardiac Surgery.
Xie Y; Guo Q; Yang B; Xie P; Zhang J; Lu W; Ronco C; Jiang G
Cardiorenal Med; 2024; 14(1):251-260. PubMed ID: 38588650
[TBL] [Abstract][Full Text] [Related]
14. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
[TBL] [Abstract][Full Text] [Related]
15. Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study.
Mayer T; Bolliger D; Scholz M; Reuthebuch O; Gregor M; Meier P; Grapow M; Seeberger MD; Fassl J
J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2072-2079. PubMed ID: 28803769
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
17. Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study.
Ferrari F; Romero-González G; Topete LR; Senzolo M; Lorenzin A; Husain-Syed F; Puci MV; Ferraro OE; Muraro E; Serrano-Soto M; Triviño AM; Castro AC; Xie Y; Yang B; De Cal M; Corradi V; Brendolan A; Scarpa M; Carta MR; Giavarina D; Bonato R; Ronco C
Sci Rep; 2019 Nov; 9(1):16484. PubMed ID: 31712687
[TBL] [Abstract][Full Text] [Related]
18. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
[TBL] [Abstract][Full Text] [Related]
20. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
